GNH USA

Europe — EMA

Lamivudina E Zidovudina Mylan

GNH USA supplies Lamivudina E Zidovudina Mylan (Zidovudine/Lamivudine), a nucleoside reverse transcriptase inhibitor for HIV-1 infection and AIDS.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Zidovudine, the active ingredient in Lamivudina E Zidovudina Mylan, is a nucleoside reverse transcriptase inhibitor presented as an oral tablet for oral use. It is used to treat HIV-1 infection and AIDS in adults and children. GNH USA supplies Lamivudina E Zidovudina Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Zidovudine, Lamivudine used for?

Lamivudina E Zidovudina Mylan is an antiretroviral medication used in the management of HIV infection and related conditions. - HIV-1 infection: reduces viral load and helps restore immune function. - AIDS: slows disease progression and decreases opportunistic infections. - Prevention of mother‑to‑child transmission: lowers the risk of HIV transmission from mother to infant during pregnancy, delivery, or breastfeeding.

What are the side effects of Zidovudine, Lamivudine?

Adverse reactions may occur with Lamivudina E Zidovudina Mylan and are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Fatigue: generalized tiredness. - Anemia: reduced red blood cell count causing pallor.

Serious or Rare Side Effects: - Severe lactic acidosis: buildup of lactic acid requiring urgent care. - Hepatic steatosis: fatty changes in the liver that may impair function. - Bone marrow suppression: marked decrease in blood cell production leading to infection risk.

What precautions apply to Zidovudine, Lamivudine?

Before using Lamivudina E Zidovudina Mylan, consider the following safety measures. - Pregnancy: Category C; discuss risks with a healthcare professional. - Breastfeeding: Evaluate benefits versus potential infant exposure. - Liver disease: Monitor hepatic function regularly. - Hematologic disorders: Conduct baseline and periodic blood counts. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture.

What does Zidovudine, Lamivudine interact with?

Lamivudina E Zidovudina Mylan may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Didanosine: increased risk of peripheral neuropathy. - Stavudine: heightened mitochondrial toxicity. - Certain protease inhibitors: may elevate zidovudine plasma levels.

Moderate Interactions (Monitor Closely): - Trimethoprim‑sulfamethoxazole: potential for additive bone marrow suppression. - Non‑nucleoside reverse transcriptase inhibitors: may require dose adjustment.

Frequently asked questions

What is Lamivudina E Zidovudina Mylan used for?+
Lamivudina E Zidovudina Mylan is an antiretroviral combination of zidovudine and lamivudine used to treat HIV‑1 infection and AIDS. It helps lower the amount of virus in the body, supports immune recovery, and can be part of regimens to prevent mother‑to‑child transmission.
How does zidovudine work in this product?+
Zidovudine is a nucleoside analogue that, after cellular phosphorylation, mimics the natural building blocks of viral DNA. When incorporated by HIV reverse transcriptase, it terminates the growing DNA chain, halting viral replication. Lamivudine works through a similar mechanism, providing a synergistic effect.
What is the usual dose of Lamivudina E Zidovudina Mylan?+
The specific dose and dosing schedule are determined by the prescribing clinician based on the patient’s age, weight, disease stage, and other medications. Healthcare providers follow established guidelines and adjust therapy as needed.
Is Lamivudina E Zidovudina Mylan safe during pregnancy or breastfeeding?+
Zidovudine/lamivudine is classified as Pregnancy Category C, meaning risk cannot be ruled out. It may be used when the potential benefits justify the risks. Breastfeeding decisions should be made with a healthcare professional, weighing maternal benefits against possible infant exposure.
How do I order Lamivudina E Zidovudina Mylan from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does this combination compare with other antiretroviral options?+
Zidovudine/lamivudine offers a well‑studied, dual‑nucleoside regimen with proven efficacy. Compared with newer integrase inhibitors, it may have a different side‑effect profile, such as higher rates of anemia, but remains a cost‑effective option in many treatment guidelines.
What are the storage requirements for Lamivudina E Zidovudina Mylan?+
Store the tablets at ambient temperature, below 25 °C, in the original container. Protect them from moisture and direct sunlight to maintain stability throughout the shelf life.
How is Lamivudina E Zidovudina Mylan administered?+
The medication is taken orally, usually with food or a glass of water, as directed by the prescriber. Swallow the tablet whole; do not crush or chew unless specifically instructed.
What are the most serious risks associated with this medication?+
Serious risks include severe lactic acidosis, hepatic steatosis, and bone‑marrow suppression leading to anemia or neutropenia. Patients should be monitored regularly for signs of metabolic disturbances, liver dysfunction, and blood‑cell abnormalities.
Who should not use Lamivudina E Zidovudina Mylan?+
Individuals with known hypersensitivity to zidovudine, lamivudine, or any excipients should avoid the product. Caution is also advised for patients with severe liver disease, pre‑existing bone‑marrow disorders, or those receiving contraindicated drug combinations.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Mylan S.P.A.
Origin
EU

Related products